Patrik Brundin, M.D., Ph.D. (Sweden) is a Professor of Neuroscience at the Neuronal Survival Unit, Department of Experimental Medical Science, at Lund University. He finished his Ph.D. at Lund University in 1988 and became a M.D. in 1992. In 1987, he was the cell biologist responsible for the tissue used in the first Swedish clinical trials with neural transplantation in humans. So far he has participated in clinical trials with intracerebral grafts in 19 Parkinsonian patients. The overall objectives of his research are to refine neural grafting for Parkinson`s disease, explore brain plasticity in the context of adult neurogenesis and to improve our understanding of Huntington`s disease pathogenesis in order to develop biomarkers and novel therapies. The specific aims are to develop human embryonic stem cells as a source for transplantation in Parkinson`s disease; to examine neurogenesis in the adult brain as a source of plasticity; and to explore neuropathology and pathogenetic mechanisms in Huntington`s disease. Brundin has received many international awards and has over 250 publications. He is the co-ordinator of several national and international research networks of excellence.